We serve 4-chloro-1-benzothiophene CAS:66490-33-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-chloro-1-benzothiophene
CAS.NO: 66490-33-3
Synonyms:
c4-chlorobenzo<b>thiophene
4-Chlor-benzo[b]thiophen
Benzo[b]thiophene,4-chloro
Molecular Formula: C8H5ClS
Molecular Weight: 168.64300
Physical and Chemical Properties:
Density: 1.3±0.1 g/cm3
Boiling point: 261.5±13.0 °C at 760 mmHg
Melting point:/
Flash point: 147.6±6.5 °C
Refractive index: 1.683
Specification:
Appearance: White solid or light yellow liquid
Purity:≥98.0%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of BrexpiprazoleCAS:913611-97-9
Contact us for information like 4-chloro-1-benzothiophene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzo[b]thiophene,4-chloro physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chlor-benzo[b]thiophen Use and application,4-Chlor-benzo[b]thiophen technical grade,usp/ep/jp grade.
Related News: The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant’s collection.(R)-1-(3,5-Bis-Trifluoromethyl-Phenyl)-Ethanol manufacturer “Traditional medicine is a treasure of Chinese civilization embodying the wisdom of the nation and its people,” Xi said at the meeting in Beijing.methyl 4-chloropyridine-2-carboxylate,hydrochloride supplier The WHO says humans are mostly infected with MERS through direct or indirect contact with infected dromedary camels, and human-to-human transmission is rare.Trimethylsilyl trifluoromethanesulfonate vendor Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.
